HDAC5 and lung carcinoma: Recent studies have reported the aberrant overexpression of HDAC5 in hepatocellular carcinoma [5] and high-risk medulloblastoma [6], whereas HDAC5 downregulation has been reported in colon cancer [7] and is associated with poor prognosis in lung cancer patients [8].